InFUSE Holdings, Inc.

InFUSE Holdings, Inc. operates ambulatory infusion centers that deliver essential infusion therapies, ensuring quality healthcare through optimized workflows and patient-centered care. InFUSE Holdings, Inc. is focused on enhancing healthcare delivery with its network of ambulatory infusion centers.

The company is headquartered in Bethesda, US. In November 2019, InFUSE Holdings raised an undisclosed amount in a SERIES A funding round led by BroadOak Capital Partners, making it the investment target. The company has completed a total of 1 deal as of the most recent deal date. InFuse Holdings specializes in the operation of high-quality, cost-effective ambulatory infusion centers, addressing gaps in the U.

S. healthcare infrastructure for infusion treatments. Their facilities provide intravenous therapies for a variety of conditions including autoimmune diseases, infections, and cancer, with a strong emphasis on patient satisfaction and optimized care processes. By creating a streamlined, patient-centered environment, they enhance the overall experience for both patients and healthcare providers across urban and suburban markets.

InFuse Holdings generates revenue through its ambulatory infusion centers by billing for infusion therapy services provided to patients, often referred by healthcare professionals. The company collaborates with payors such as insurance companies to ensure coverage for services rendered, and implements a pricing model tailored to specific treatments. This structure supports reduced costs for patients compared to alternative options in healthcare delivery. InFUSE Holdings plans to leverage the recent SERIES A funding from November 2019 to expand its network of ambulatory infusion centers.

The company is targeting new geographic regions to enhance access to infusion therapies, with plans to introduce additional service offerings aimed at improving patient outcomes. Specific markets and release dates for new products are currently in development, aimed at responding to the growing demand for efficient healthcare delivery models.